Conspectus
Protein post-translational modification (PTM)
is a major mechanism
for functional diversification of the human genome and plays a crucial
role in almost every aspect of cellular processes, and the dysregulation
of the protein PTM network has been associated with a variety of human
diseases. Using high-resolution mass spectrometry, protein PTMs can
be efficiently discovered and profiled under various biological and
physiological conditions. However, it is often challenging to address
the biological function of PTMs with biochemical and mutagenesis-based
approaches. Specifically, this field lacks methods that allow gain-of-function
studies of protein PTMs to understand their functional consequences
in living cells. In this context, the genetic code expansion (GCE)
strategy has made tremendous progress in the direct installation of
PTMs and their analogs in the form of noncanonical amino acids (ncAAs)
for gain-of-function investigations.
In addition to studying
the biological functions of known protein
PTMs, the discovery of new protein PTMs is even more challenging due
to the lack of chemical information for designing specific enrichment
methods. Genetically encoded ncAAs in the proteome can be used as
specific baits to enrich and subsequently identify new PTMs by mass
spectrometry.
In this Account, we discuss recent developments
in the investigation
of the biological functions of protein PTMs and the discovery of protein
PTMs using new GCE strategies. First, we leveraged a chimeric design
to construct several broadly orthogonal translation systems (OTSs).
These broad OTSs can be engineered to efficiently incorporate different
ncAAs in both E. coli and mammalian cells. With these
broad OTSs, we accomplish the following: (1) We develop a computer-aided
strategy for the design and genetic incorporation of length-tunable
lipidation mimics. These lipidation mimics can fully recapitulate
the biochemical properties of natural lipidation in membrane association
for probing its biological functions on signaling proteins and in
albumin binding for designing long-acting protein drugs. (2) We demonstrate
that the binding affinity between histone methylations and their corresponding
readers can be substantially increased with genetically encoded electron-rich
Trp derivatives. These engineered affinity-enhanced readers can be
applied to enrich, image, and profile the interactome of chromatin
methylations. (3) We report the identification and verification of
a novel type of protein PTM, aminoacylated lysine ubiquitination,
using genetically encoded PTM ncAAs as chemical probes. This approach
provides a general strategy for the identification of unknown PTMs
by increasing the abundance of PTM bait probes.